Primary duodenal follicular lymphoma treated with rituximab monotherapy and followed-up for 15 years

Anna Seki, Masaya Iwamuro, Masao Yoshioka, Nobuharu Fujii, Hiroyuki Okada, Soichiro Nose, Katsuyoshi Takata, Tadashi Yoshino, Kazuhide Yamamoto

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

A 41-year-old woman was diagnosed with duodenal follicular lymphoma. She had no other lesions and was assigned to a "watch and wait" policy. Swelling of the inguinal lymph nodes appeared 45 months later, and rituximab monotherapy resulted in complete remission. However, follicular lymphoma recurred in the stomach, rectum and mesenteric and external iliac lymph nodes 81 months after the therapy. The patient received rituximab monotherapy again and has remained in complete remission in the fifteenth year after the initial diagnosis. This case suggests the usefulness of rituximab monotherapy in the long-term management of intestinal follicular lymphoma.

Original languageEnglish
Pages (from-to)301-306
Number of pages6
JournalActa medica Okayama
Volume69
Issue number5
Publication statusPublished - 2015

Keywords

  • Duodenum
  • Follicular lymphoma
  • Rituximab

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Primary duodenal follicular lymphoma treated with rituximab monotherapy and followed-up for 15 years'. Together they form a unique fingerprint.

Cite this